Although academic writing about risk as a conceptual and theoretical category has burgeoned in recent years, debates about the characteristics of the risk society have tended to by-pass more mundane but ubiquitous dimensions of health and health-related behaviour. In this article, we argue that focusing on lay people’s understanding of the risks of a relatively commonplace example of modern medical technology (the use of non-prescription medicines for the self-medication of minor ailments) provides an insight and a challenge to what theorists of the risk society have described as the existential contours of life in late modernity.
In the context of an empirical study detailing consumer responses to a naturally occurring risk, we explore some of the arguments proposed by Ulrich Beck and amplified by Anthony Giddens concerning the characteristics of the risk society. We provide evidence both for and against the propositions described by these authors and posit a more nuanced understanding of the risks of scientific medicine which acknowledges both lay expertise over medicines usage coupled with dependence on medicine and medical technology as forms of healing.
Alaszewski, A. (1998). Risk, health and welfare. Milton Keynes: Open University Press.
3.
Alkami, A.S. and Slovic, P. (1994). A psychological study of the inverse relationship between perceived risk and perceived benefit. Risk Analysis, 14, 1085–1096.
4.
Anon . (1997a). Pharmacists asked to move terfenadine products into the dispensary. Pharmaceutical Journal, 258, 581-581.
5.
Anon . (1997b). Grapefruit juice and terfenadine: the ‘final straw’. Pharmaceutical Journal, 258, 618-618.
Arluke, A. (1980). Judging drugs: patients’ conceptions of therapeutic efficacy in the treatment of arthritis. Human Organisation, 39, 84–88.
8.
Asbury, J.-E. (1995). Overview of focus group research. Qualitative Health Research, 5, 414–420.
9.
Barber, N. (1993). Drugs: from prescription only to pharmacy only. British Medical Journal, 307, 640-640.
10.
Barter, G. and Cormack, M. (1996). The long-term use of benzodiazepines: patients’ views, accounts and experiences. Family Practice, 13, 491–497.
11.
Beck, U. (1992). Risk society: towards a new modernity. London: Sage.
12.
Bissell, P. , Ward, P.R. and Noyce, P.R. (1997a). Variations within community pharmacy: I Requesting over the counter medicines. Journal of Social and Administrative Pharmacy, 14, 1–15.
13.
Bissell, P. , Ward, P.R. and Noyce, P.R. (1997b). Variations within community pharmacy: II Presenting symptoms. Journal of Social and Administrative Pharmacy, 14, 105–115.
14.
Blaxter, M. (1983). The causes of disease: women talking. Social Science and Medicine, 17(2), 59–69.
15.
Blaxter, M. and Britten, N. (1996). Lay beliefs about drugs and medicines and the implications for community pharmacy. Report produced for the Pharmacy Practice Research Resource Centre, University of Manchester.
16.
Blenkinsopp, A. and Bradley, C. (1996). Patients, society and the increase in self medication. British Medical Journal, 312, 629–632.
17.
Britten, N. (1996). Lay views of drugs and medicines: orthodox and unorthodox accounts. In S.J. Williams and M. Calnan (Eds.), Modern medicine: lay perspectives and experiences. London: UCL Press.
18.
Brown, P. (1992). Popular epidemiology and toxic waste contamination: lay and professional ways of knowing. Journal of Health and Social Behaviour, 33, 267–281.
19.
Busby, H. , Williams, G. and Rogers, A. (1998). Bodies of knowledge: lay and biomedical understandings of musculoskeletal disorders. In M.A. Elston (Ed.), The sociology of medical science and technology. Oxford: Blackwell Publishers.
20.
Calnan, M. (1987). Health and illness: the lay perspective. London: Tavistock.
21.
Conrad, P. (1985). The meaning of medications: another look at compliance. Social Science and Medicine, 23, 641–650.
22.
Consumers’ Association . (1994). Over-the-counter medicines. No prescription necessary. Which?, 38–41.
23.
Consumers’ Association . (1996). Pharmacists in crisis. Which?, 18–21.
24.
Consumers’ Association . (1999). Are pharmacists asking the right questions?Which?, 27–29.
25.
Cornwell, J. (1984). Hard-earned lives: accounts of health and illness from East end London. London: Tavistock.
26.
Dean, M. (1994). Critical and effective histories: Foucault’s methods and historical sociology. London: Routledge.
27.
Denzin, N.K. and Lincoln, Y.S. (1998).The landscape of qualitative research. Theories and issues. Thousand Oaks, CA: Sage.
28.
Desvousges, W.H. and Smith, V.K. (1988). Focus groups and risk communication: the ‘science’ of listening to data. Risk Analysis, 8, 479–484.
29.
Donovan, J.L. and Blake, D.R. (1992). Patient non-compliance: deviance or reasoned decision-making?Social Science and Medicine, 34, 507–513.
30.
Douglas, M. (1986). Risk acceptability according to the social sciences. London: Routledge & Kegan Paul.
31.
Douglas, M. (1992). Risk and blame: essays in cultural theory. London: Routledge.
32.
Douglas, M. and Wildavsky, A. (1982). Risk and culture: an essay on the selection of technological and environmental dangers. Berkeley, CA: University of California Press.
33.
Drummond, N. and Mason, C. (1990). Diabetes in a social context: just a different way of life in the age of reason. In S. Cunningham-Burley and N.P. McKeganey (Eds.), Readings in medical sociology. London: Routledge.
34.
Frankland, J. and Bloor, M. (1997). Some issues arising from the systematic analysis of focus group materials. In R. Barbour and J. Kitzinger (Eds.), The use of focus groups in health research, 1st edn.London: Sage.
35.
Gabe, J. (Ed.). (1995). Medicine, health and risk. Sociological approaches. Oxford: Blackwell Publishers.
36.
Gabe, J. and Bury, M. (1996). Risking tranquiliser use: cultural and lay dimensions. In S.J. Williams and M. Calnan (Eds.), Modern medicine. Lay perspectives and experiences. London: UCL Press.
37.
Geertz, C. (1973). The interpretation of cultures. New York: Basic Books.
38.
Giddens, A. (1990). The consequences of modernity. Cambridge: Polity Press.
39.
Giddens, A. (1991). Modernity and self identity. Cambridge: Polity Press.
40.
Hayes, M.V. (1992). On the epistemology of risk: language, logic and social science. Social Science and Medicine, 35, 401–407.
41.
Heyman, B. (1998). Risk, health and health care. London: Hodder & Stoughton.
42.
Higgs, P. (1998). Risk, governmentality and the reconceptualization of citizenship. In G. Scambler and P. Higgs (Eds.), Modernity, medicine and health. Medical sociology towards 2000. London: Routledge.
43.
Kitzinger, J. (1995). Introducing focus groups. British Medical Journal, 311, 299–302.
44.
Kreuger, R.A. (1994). Focus groups: a practical guide for applied research. Thousand Oaks, CA: Sage.
45.
Krska, J. and Kennedy, E. (1996). An audit of responding to symptoms in community pharmacy. International Journal of Pharmacy Practice, 4, 129–135.
46.
Lane, K. (1995). The medical model of the body as a site of risk: a case study of childbirth. In J. Gabe (Ed.), Medicine, health and risk. Sociological approaches. Oxford: Blackwell.
47.
Lash, S. (1994). Reflexive modernization: politics, tradition and aesthetics in the modern state. Cambridge: Polity Press.
48.
Mason, J. (1996). Qualitative researching. London: Sage.
49.
Morgan, D.L. (Ed.). (1993). Successful focus groups: advancing the state of the art. Newbury Park, CA: Sage.
50.
Morgan, M. (1996). Perceptions and use of anti-hypertensive drugs among cultural groups. In S.J. Williams and M. Calnan (Eds.), Modern medicine. Lay perspectives and experiences. London: UCL Press.
51.
Myers, L.B. and Midence, K. (1998) Adherence to treatment in medical conditions. Australia: Harwood Academic Publishers.
52.
National Pharmaceutical Association . (1998). NPA newsletter, October.
53.
Oster, G. , Huse, D.M., Delea, T.E., Colditz, G.A. and Richter, L.M. (1990). The risks and benefits of an Rx-to-OTC switch. The case of over-the-counter H2-blockers. Medical Care, 28, 834–849.
54.
Payne, K. , Ryan-Woolley, B.M. and Noyce, P.R. (1998). Role of consumer attributes in predicting the impact of medicines deregulation on National Health Service prescribing in the United Kingdom. International Journal of Pharmacy Practice, 6, 150–158.
55.
Phillimore, P. and Moffat, S. (1994). Discounted knowledge: local experience, environmental pollution and health. In J. Popay and G. Williams (Eds.), Researching the people’s health. London: Routledge.
56.
Plummer, K. (1983) Documents of life. London: George Allen & Unwin. Quoted in Chapple, A. and Rogers, A. (1998). Explicit guidelines for qualitative research: a step in the right direction, a defence of the soft option, or a form of sociological imperialism? Family Practice, 15(6), 556–561.
57.
Popay, J. , Rogers, A. and Williams, G. (1998). Rationale and standards for the systematic review of qualitative literature in health services research. Qualitative Health Research, 8, 341–351.
58.
Radley, A. and Billig, M. (1996). Accounts of health and illness: dilemmas and representations. Sociology of Health and Illness, 18, 220–240.
59.
Rogers, A. and Pilgrim, D. (1995). The risk of resistance: perspectives on the mass childhood immunisation programme. In J. Gabe (Ed.), Medicine, health and risk. Sociological approaches. Oxford: Blackwell.
60.
Royal Society . (1992). Risk: analysis, perception and management. Report of the Royal Society Study Group. London: The Royal Society.
61.
Sharma, U. (1996). Using complementary therapies: a challenge to orthodox medicine? In S.J. Williams and M. Calnan (Eds.), Modern medicine. Lay perspectives and experiences. London: UCL Press.
62.
Slovic, P. (1987). Perception of risk. Science, 236, 280–285.
63.
Slovic, P. (1992). Perceptions of risk: reflections on the psychometric paradigm. In S. Krimsky and D. Golding (Eds.), Social theories of risk. New York: Praeger.
64.
Slovic, P. , Fischhoff, B. and Lichtenstein, S. (1990). Facts versus fears: understanding perceived risk. In D. Kahnemann, P. Slovic and A. Tversky (Eds.), Judgement under uncertainty: heuristics and biases. Cambridge: Cambridge University Press.
65.
Taylor-Gooby, P. , Dean, H., Munro, M. and Parker, G. (1998). Risk and the welfare state. Paper presented at the ESRC Economic Beliefs and Behaviour Programme conference on ‘Decision making in theory and practice’, University of Oxford, 1–2 July.
66.
Van der Geest, S. and Whyte, S.R. (1989). The charm of medicines: metaphors and metonyms. Medical Anthropology Quarterly, 3, 345–367.
67.
Vaughan, E. and Seifert, M. (1992). Variability in the framing of risk issues. Journal of Social Issues, 48(4), 119–135.
68.
Vuckovic, N. and Nichter, M. (1997). Changing patterns of pharmaceutical practice in the United States. Social Science and Medicine, 44, 1285–1302.
69.
Ward, P.R. and Tully, M.P. (1998). Self-care and pharmacy: setting the research agenda. Report to the Royal Pharmaceutical Society. London: Royal Pharmaceutical Society of Great Britain.
70.
Williams, G. (1984). The genesis of chronic illness: narrative reconstruction. Sociology of Health and Illness, 6, 175–200.
71.
Williams, G. and Popay, J. (1994). Lay knowledge and the privilege of experience. In J. Gabe, D. Kelleher and G. Williams (Eds.), Challenging medicine. London: Routledge.
72.
Williams, G. , Popay, J. and Bissell, P. (1995). Public health movements in the material world: barriers to social movements in health. In J. Gabe (Ed.), Medicine, health and risk. Sociological approaches. Oxford: Blackwell.
73.
Williams, S.J. and Calnan, M. (1996) Conclusions: modern medicine and the lay populace in late modernity. In S.J. Williams and M. Calnan (Eds.), Modern medicine. Lay perspectives and experiences. London: UCL Press.
74.
Wynne, B. (1992). Misunderstood misunderstanding: social identities and the public uptake of science. Public Understanding of Science, 1, 281–304.
75.
Wynne, B. (1996). May the sheep safely graze? A reflexive view of the expert–lay knowledge divide. In S. Lash, B. Szerszynski and B. WynneRisk, environment and modernity: towards a new ecology. London: Sage.
